Rheumatology (Oxford, England)
Real-world experience of anifrolumab in 30 patients with refractory dermatomyositis: a multicenter-multidisciplinary retrospective study.
Míriam Retuerto-Guerrero, Clara Moriano Morales, Ana Pareja-Martínez, Natalia Molina-Esteban, Jose Puig-Buendia, Concepción Postigo Llorente, Ana Lopez-Ceron Cofiño, Julia Martínez-Barrio, Paola Vidal-Montal, Elena Sendagorta Cudos, Luisa Martos Cabrera, Guillermo González Arribas, Jaime Calvo Alén, Juan Ramón De Dios, Juan María Blanco Madrigal
Published: 202510.1093/rheumatology/keaf662
Abstract
OBJECTIVE: To assess real-world outcomes of anifrolumab (ANI) in refractory systemic DM. METHODS: This multicentre and multidisciplinary, retrospective study evaluated 30 DM patients receiving ANI through compassionate use. Disease activity was asses…
Preview only. Read the full abstract at the source